<!DOCTYPE HTML>
<html>
  <head>
    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8">
    <title>Monitoring, Referrals and Warnings</title>
	</head>
  <body onLoad="init();">
    <div data-role="page" data-theme="a">
  	<div data-role="header" data-theme="b" data-position="inline">
    	<h1>Monitoring, Referrals and Warnings</h1> 
    	<a href="#" data-rel="back" data-icon="arrow-l" data-direction="reverse" >Back</a>
	</div>
    <div data-role="content">
  <p><i>Naltrexone:</i> Oral and IM baseline evaluation include liver transaminase, bilirubin and urine beta-HCG for females. Naltrexone IM also should have baseline CR levels drawn. Repeat naltrexone liver transaminase levels at 6 and 12 months and then every 12 months thereafter. Naltrexone IM may cause allergic pneumonia, monitor appropriately. Monitor for signs and symptoms of acute hepatitis occur, discontinue naltrexone if signs appear and contact provider immediately. Patients who have previously used Opioids may be more sensitive to toxic effects of Opioids after discontinuation of naltrexone.</p> 
    <p><i>Disulfiram:</i> If the patient consumes alcohol with disulfiram then a disulfiram-alcohol reaction will occur and may persist for 30 minutes to several hours afterwards. Reaction can include flushing, throbbing in the head or neck, nausea, vomiting, sweating, chest pain, palpitation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision and confusion. Severe reactions include respiratory depression, cardiovascular collapse, arrhythmias, MI, convulsions and death. Warn patients accordingly. Family members should not administer disulfiram without informing the patient. Provide patients with wallet cards that indicate the use of disulfiram.</p> 
    <p>Monitor closely for suicidal thoughts and depression.</p>
    </div><!-- end jqm content -->
   
    </div><!-- end jqm page -->
  </body>
</html>
